NCLAT: Can’t Set Aside Liquidation Order u/s 33 IBC When 3rd Party has Taken Possession of Property || NCLAT: Unless Amendment Application Filed, Authority Can’t Suo Motu Amend Date of Default || Delhi HC Directs Removal of 'Kindpan' Trademark in Petition Filed by ‘Mankind’ || J&K HC: Limitation for Challenging Award Starts after Signed Copy is Received by Party || Delhi HC: ‘High Speed’ Not Sufficient to Conclude Driver Acted in Rash and Negligent Manner || Allahabad HC: Huge Difference between Executing a Particular Document and Being a Witness || Kerala HC: Can’t Consider Co-Opted Members of Bar Council as Separate Class from Elected Members || J&K HC: Govt. Failing to Communicate Rejection of Detenue’s Representation in Time Vitiates Order || SC: Electricity Act Empowers State Commissions to Regulate Open Access Within their Respective States || SC: Limitation Begins from Date of Registration of Sale Deed that Constitutes Constructive Notice

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS BILL 2015 ETHICS COMMITTEE

Share :